Skip to main content

Clover Health Investments, Corp.

corporate_fare Company Profile

Clover Health Investments, Corp.

CLOV·NASDAQ·Finance·CIK 0001801170

Clover Health aims to empower physicians with technology to identify, manage, and treat chronic diseases earlier, leading to earlier diagnosis and treatment, earlier disease management, and more affordable and accessible care. The company's strategy involves improving care for its Medicare Advantage ("MA") members, developing extensive physician networks, and providing technology to support physicians. Its proprietary software platform, Clover Assistant, also licensed externally as Counterpart Assistant, supports real-time clinical decision-making at the point of care by providing clinicians with data and insights. This cloud-based software platform curates data from over 100 sources, offering physicians access to data-driven insights and personalized care recommendations for patients. Provider use of Clover Assistant enables data-driven clinical decision-making, benefiting members and driving rapid software iteration. The more providers use Clover Assistant, the more it learns and refines the precision of personalized data-driven recommendations. Clover Health combines beneficiary data with provider-generated data, using this feedback loop to continuously fine-tune its proprietary clinical rules and machine learning models, and to prioritize future software capabilities.

Clover Health Investments, Corp. (NASDAQ:CLOV) is a publicly traded company in the Finance sector. Wiseek has independently scored 26 items for CLOV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for CLOV spans 10-Q, 8-K, 144, DEF 14A.

Recent high-impact activity:

  • Clover 10-Q: Q3 Net Income $6.4M, Nine-Month Profit $61.8M, Cash $512.6M
  • Clover Health Posts $6.4M Q3 Profit, Raises Full-Year 2026 Guidance Across All Metrics
  • Clover Health Tops Q3 Estimates With $759M Revenue and $16M Adjusted EBITDA
  • Clover Health PPO Plans Land 5-Star CMS Rating, Unlocking Year-Round Enrollment
  • Clover Health Swings to Profit in Q2, Raises Full-Year Outlook on Membership Surge

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.92B
Net Income
-$85.55M
Op. Cash Flow
-$66.93M
Free Cash Flow
-$68.98M
Operating Income
-$85.53M
Cash & Equivalents
$78.3M
Debt / Equity
0.00×
Net Margin
-4.4%
Shares Outstanding
511.97M sh
Source: 10-K · filed 2026-02-27 · accession 0001801170-26-000057

Short Interest & Short Volume

6.73 days to cover

FINRA reported short interest of 23,025,747 shares in CLOV as of the October 30, 2026 settlement, a 11.3% decrease from the prior period — about 6.7 days to cover at its recent average daily volume. On November 19, 2026, 50.8% of CLOV volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)23,025,747 shares as of October 30, 2026
Change vs prior period▼ 11.3%
Days to cover6.73 at avg daily volume of 3,422,422
Daily short volume (FINRA facilities)50.8% of 4,029,181 shares on November 19, 2026
5-day average short volume38.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$3.71 -1.59% today
52-week range · as of 2026-11-06 $1.58 – $5.59
Market cap
$1.98B
Volume
5.8M (1.2× avg)
3-mo avg 4.7M
Live data · 2026-11-20 20:56 UTC · Market open

show_chartPrice Chart

Loading chart...

feed CLOV - Latest Insights

CLOV
Nov 06, 2026, 8:03 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.45
Real-time Price: $3.71 info
Change: -$0.7402 (-17%) info
Market Cap: $1.976B info
CLOV
Nov 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.67
Real-time Price: $3.71 info
Change: -$0.960 (-21%) info
Market Cap: $1.976B info
CLOV
Nov 04, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $4.71
Real-time Price: $3.71 info
Change: -$1.00 (-21%) info
Market Cap: $1.976B info
CLOV
Oct 08, 2026, 6:45 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $3.71 info
Change: -$1.29 (-26%) info
Market Cap: $1.976B info
CLOV
Aug 07, 2026, 8:04 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.69
Real-time Price: $3.71 info
Change: -$0.980 (-21%) info
Market Cap: $1.976B info
CLOV
Jul 17, 2026, 5:49 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.61
Real-time Price: $3.71 info
Change: -$0.900 (-20%) info
Market Cap: $1.976B info
CLOV
Jul 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.62
Real-time Price: $3.71 info
Change: -$0.908 (-20%) info
Market Cap: $1.976B info
CLOV
Jul 07, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.04
Real-time Price: $3.71 info
Change: -$1.33 (-26%) info
Market Cap: $1.976B info
CLOV
Jun 18, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $4.93
Real-time Price: $3.71 info
Change: -$1.22 (-25%) info
Market Cap: $1.976B info
CLOV
Jun 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.93
Real-time Price: $3.71 info
Change: -$1.22 (-25%) info
Market Cap: $1.976B info
CLOV
Jun 10, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.24
Real-time Price: $3.71 info
Change: -$0.530 (-13%) info
Market Cap: $1.976B info
CLOV
May 18, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.38
Real-time Price: $3.71 info
Change: +$0.330 (+10%) info
Market Cap: $1.976B info
CLOV
May 14, 2026, 3:20 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $3.71 info
Change: +$0.230 (+7%) info
Market Cap: $1.976B info
CLOV
May 08, 2026, 8:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.79
Real-time Price: $3.71 info
Change: +$0.9198 (+33%) info
Market Cap: $1.976B info
CLOV
May 08, 2026, 8:06 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.81
Real-time Price: $3.71 info
Change: +$0.903 (+32%) info
Market Cap: $1.976B info
CLOV
May 06, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.70
Real-time Price: $3.71 info
Change: +$1.01 (+37%) info
Market Cap: $1.976B info
CLOV
Apr 28, 2026, 4:06 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $2.61
Real-time Price: $3.71 info
Change: +$1.10 (+42%) info
Market Cap: $1.976B info
CLOV
Apr 01, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.73
Real-time Price: $3.71 info
Change: +$1.98 (+114%) info
Market Cap: $1.976B info
CLOV
Mar 19, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.88
Real-time Price: $3.71 info
Change: +$1.83 (+97%) info
Market Cap: $1.976B info
CLOV
Mar 10, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $3.71 info
Change: +$1.71 (+86%) info
Market Cap: $1.976B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets